The presentation will be accessible via a Webcast through a link posted on the Investor Relations, Events Calendar section of the
About
MOVANTIK™ is a trademark and MOVENTIG® is a registered trademark of the AstraZeneca group of companies.
Contact:
Investors
415-482-5585
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nektar-therapeutics-president-and-ceo-howard-w-robin-to-present-at-the-jefferies-2015-global-healthcare-conference-in-new-york-city-300090011.html
SOURCE
News Provided by Acquire Media